ADPT News and Press, Adaptive Biotechnologies Corporation

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that its next-generation sequen...

2024-05-29 20:54:18 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value decreased from $27.3B to $26.9B in Q1 2024. The number of holdings in the portfolio increased from 79 to 83. The largest five individual stock positions are Visa, Workday, Amazon.com, Philip Morri...

SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating ...

2024-05-23 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips To be completely upfront, small-cap stocks to buy are risky. They’re the equivalent of plus-money bets or plus odds. Let me explain. In the world of sports gambling, you have the opt...

2024-05-15 09:45:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. The U.S. equity market continued to ra...

2024-05-15 09:10:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. For the first quarter of 2024, Aristot...

2024-05-15 09:00:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. U.S. economic growth remained positive...

2024-05-08 18:43:24 ET Adaptive Biotechnologies (NASDAQ: ADPT) , a company that, in its own words, "aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease," was the cure for the stock market blahs on Wednesday. The commercia...

2024-05-07 20:59:07 ET Adaptive Biotechnologies Corporation. (ADPT) Q1 2024 Earnings Conference Call May 07, 2024, 16:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - CEO and Co-founder Kyle Piskel - CFO Susan Bobulsky - Senior Vice Pr...

2024-05-07 16:46:31 ET More on Adaptive Biotechnologies Adaptive Biotechnologies: A Post Earnings Assessment Adaptive Biotechnologies Corporation (ADPT) Q4 2023 Earnings Call Transcript Adaptive Biotechnologies Corporation 2023 Q4 - Results - Earnings Call Presentati...